This study tests a custom-made drug called an antisense oligonucleotide (ASO) designed for one child with a rare, severe genetic brain disorder. The drug aims to correct the specific genetic mistake causing the disease. The trial focuses on safety and how the drug moves through t…
Phase: PHASE1, PHASE2 • Sponsor: EveryONE Medicines Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC